World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia – a short version for primary care
出版年份 2017 全文链接
标题
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia – a short version for primary care
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
Volume 21, Issue 2, Pages 82-90
出版商
Informa UK Limited
发表日期
2017-02-25
DOI
10.1080/13651501.2017.1291839
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial
- (2016) Robert M Anthenelli et al. LANCET
- Metformin treatment of antipsychotic-induced dyslipidemia: an analysis of two randomized, placebo-controlled trials
- (2016) R-R Wu et al. MOLECULAR PSYCHIATRY
- Augmentation of clozapine with electroconvulsive therapy in treatment resistant schizophrenia: A systematic review and meta-analysis
- (2016) John Lally et al. SCHIZOPHRENIA RESEARCH
- Electroconvulsive Therapy Augmentation in Clozapine-Resistant Schizophrenia: A Prospective, Randomized Study
- (2015) Georgios Petrides et al. AMERICAN JOURNAL OF PSYCHIATRY
- Early Improvement As a Predictor of Later Response to Antipsychotics in Schizophrenia: A Diagnostic Test Review
- (2015) Myrto T. Samara et al. AMERICAN JOURNAL OF PSYCHIATRY
- The Use of Continuous Treatment Versus Placebo or Intermittent Treatment Strategies in Stabilized Patients with Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials with First- and Second-Generation Antipsychotics
- (2015) Marc De Hert et al. CNS DRUGS
- A Randomized Comparison of Aripiprazole and Risperidone for the Acute Treatment of First-Episode Schizophrenia and Related Disorders: 3-Month Outcomes
- (2015) Delbert G. Robinson et al. SCHIZOPHRENIA BULLETIN
- World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia Part 3: Update 2015 Management of special circumstances: Depression, Suicidality, substance use disorders and pregnancy and lactation
- (2015) Alkomiet Hasan et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Schizophrenia in a Primary Care Setting
- (2015) Rose Jones et al. Current Psychiatry Reports
- Premature Mortality Among Adults With Schizophrenia in the United States
- (2015) Mark Olfson et al. JAMA Psychiatry
- Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level
- (2015) MARC DE HERT et al. World Psychiatry
- Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
- (2015) MARC DE HERT et al. World Psychiatry
- Thinking and acting beyond the positive: the role of the cognitive and negative symptoms in schizophrenia
- (2014) Maren Carbon et al. CNS SPECTRUMS
- Somatic Diseases and Conditions Before the First Diagnosis of Schizophrenia: A Nationwide Population-based Cohort Study in More Than 900 000 Individuals
- (2014) H. J. Sorensen et al. SCHIZOPHRENIA BULLETIN
- Pharmacological Strategies to Counteract Antipsychotic-Induced Weight Gain and Metabolic Adverse Effects in Schizophrenia: A Systematic Review and Meta-analysis
- (2014) Y. Mizuno et al. SCHIZOPHRENIA BULLETIN
- Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
- (2013) Stefan Leucht et al. LANCET
- Guidelines for the pharmacological treatment of anxiety disorders, obsessive–compulsive disorder and posttraumatic stress disorder in primary care
- (2012) Borwin Bandelow et al. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
- Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis
- (2012) Stefan Leucht et al. LANCET
- World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 2: Update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects
- (2012) Alkomiet Hasan et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance
- (2012) Alkomiet Hasan et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Chronic Somatic Comorbidity and Excess Mortality Due to Natural Causes in Persons with Schizophrenia or Bipolar Affective Disorder
- (2011) Thomas Munk Laursen et al. PLoS One
- Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC)
- (2009) M. De Hert et al. EUROPEAN PSYCHIATRY
- The 2009 Schizophrenia PORT Psychopharmacological Treatment Recommendations and Summary Statements
- (2009) R. W. Buchanan et al. SCHIZOPHRENIA BULLETIN
- Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial
- (2008) René S Kahn et al. LANCET
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now